查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球醫療植入物市場 - 2023-2030
市場調查報告書
商品編碼
1348008

全球醫療植入物市場 - 2023-2030

Global Medical Implants Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 181 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

醫療植入物放置在身體內部或表面，以替換缺失的生物結構，支撐受損的生物結構，並增強現有的生物結構。其他醫療植入物有助於輸送藥物，監測身體功能，併為器官和組織提供支援。

醫療植入物可以永久或暫時放置。例如，支架或髖關節植入物是永久性的，但用於修復骨折的化療端口或螺絲在不再需要時可以移除。植入物的表面由鈦、矽樹脂或磷灰石等生物醫學材料製成。

此外，技術進步的不斷進步、產品的推出和優惠的報銷政策等重要的成長動力將推動未來的市場成長。 Orthopedic Implant Company、Auxein Medical、Medtronic Plc.、Stryker Corporation 等重要參與者都在市場上積極運作。

動力學

增加醫療植體的產品發布

醫療植入物用作義肢，旨在取代缺失的身體部位。大公司推出的產品有助於推動市場成長，這些有效的產品發布有助於將研究發現轉化為新的治療方法並改善數百萬人的護理。

例如，2023 年 2 月，OSSIO, Inc. 推出了全新 OSSIO Fiber Compression Staple。 OSSIO Fiber 加壓縫合釘採用 OSSIO Fiber 智慧骨再生技術製成。 OSSIO Fiber 透過在非永久植入物中結合無與倫比的機械強度和自然骨癒合，為永久金屬硬體和傳統可吸收和同種異體移植植入物的缺點提供了第一個可靠的解決方案。

此外，雅培實驗室於 2022 年 12 月推出了名為 Navitor 的最新一代經導管主動脈瓣植入 (TAVI) 系統，為處於高或極高手術風險的嚴重主動脈瓣狹窄患者提供微創設備。因此，由於上述因素，預計市場在預測期內將會提振。

優惠報銷政策助推醫療植入物市場

報銷政策通常會考慮手術的複雜性、使用的植入物類型以及手術期間使用的相關醫療資源等因素。報銷政策在醫療植入市場中發揮著至關重要的作用，因為它們決定了向醫療保健提供者提供的用於執行植入手術的承保範圍和財務報銷水平。

例如，2023 年 3 月，Inspire Medical Systems, Inc. 表示，已在比利時獲得全國報銷批准，其費率與世界其他國家一致。此次報銷批准為在安特衛普大學醫院 (UZA) 的指導下在比利時開設更多 Inspire 植入中心提供了一條途徑，同時也擴大了醫療服務的覆蓋範圍。

此外，2022 年 11 月，Establishment Labs Holdings Inc. 宣布 Motiva Implants 和 Motiva Flora 組織擴張器已獲得藥品和醫療器材管理局 (PMDA) 批准在日本使用，這些產品還獲得了乳房切除術後的報銷日本國民保健系統下的重建。

與牙植體相關的併發症將阻礙市場的成長

植牙的併發症包括骨整合，即骨頭在植體周圍生長，並且可能會自行脫落。植牙的一項主要風險是鼻竇損傷，即上顎位於鼻竇正下方。用於替換上牙的植體可能會滲入鼻竇，導致不適或可能的感染。其他植入物也存在類似情況，因此預計這些情況將阻礙市場成長。

目錄

第 1 章：方法與範圍

  • 研究方法論
  • 報告的研究目的和範圍

第 2 章：定義與概述

第 3 章：執行摘要

  • 按產品分類
  • 按材料類型分類區隔
  • 最終用戶摘錄
  • 按地區分類區隔

第 4 章：動力學

  • 影響因素
    • 動力
      • 增加醫療植體的產品發布
      • 優惠報銷政策
    • 限制
      • 與植牙相關的併發症
    • 機會
    • 影響分析

第 5 章：產業分析

  • 波特五力分析
  • 供應鏈分析
  • 未滿足的需求
  • 監管分析
  • DMI 意見

第 6 章：COVID-19 分析

  • COVID-19 分析
    • COVID-19 之前的情況
    • COVID-19 期間的情況
    • COVID-19 後的情景
  • COVID-19 期間的定價動態
  • 供需譜
  • 疫情期間政府與市場相關的舉措
  • 製造商的策略舉措
  • 結論

第 7 章：副產品

  • 骨科植入物
    • 髖關節植入物
    • 關節置換植入物
    • 脊椎植入物
    • 其他
  • 心血管植入物
    • 起搏器
    • 植入式心臟復律去顫器 (ICD)
    • 心循環記錄儀
  • 眼科植入物
    • 三焦點鏡片
    • 擴展焦深 (EDOF) 水晶體植入
    • 單焦點晶狀體植入
  • 植牙
    • 骨內膜
    • 骨膜下
  • 美容植入物
    • 臉部植入物
    • 乳房植入物

第 8 章：依材料類型

  • 陶瓷製品
  • 金屬色
  • 聚合物
  • 其他

第 9 章：最終用戶

  • 醫院
  • 骨科中心
  • ASC
  • 心臟中心
  • 臉部美容中心
  • 牙科醫院
  • 其他

第 10 章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 亞太地區其他地區
  • 中東和非洲

第 11 章：競爭格局

  • 競爭場景
  • 產品基準化分析
  • 公司股份分析
  • 主要進展和策略

第 12 章：公司簡介

  • Orthopedic Implant Company
    • 公司簡介
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • Auxein Medical
  • Medtronic Plc.
  • Stryker Corporation
  • 4Web Medical
  • Smith & Nephew
  • Novel Biocare Services AG
  • Strauman AG
  • GS Medical
  • CurvaFix Inc.

第 13 章：附錄

簡介目錄
Product Code: MD1907

Overview

Medical implants are placed inside or on the surface of the body to replace a missing biological structure, support a damaged biological structure, and enhance an existing biological structure. Other medical implants help in delivering medication, monitor body functions, and provide support to organs and tissues.

Medical implants can either be placed permanently or temporarily. For example, stents or hip implants are intended to be permanent but chemotherapy ports or screws to repair broken bones can be removed when they are no longer needed. The surface of implants is made of a biomedical material such as titanium, silicone, or apatite.

Furthermore, significant growth drivers such as increasing technological advancements, product launches, and favorable reimbursement policies give rise to future market growth. Significant key players like Orthopedic Implant Company, Auxein Medical, Medtronic Plc., Stryker Corporation, and others are actively operating in the market.

Dynamics

Increasing Product Launches for Medical Implants

Medical implants are used as prosthetics which are intended to replace missing body parts. The product launches by major companies help to drive market growth and these effective product launches help to transform research discoveries into new treatments and improve care for millions of people.

For instance, in February 2023, OSSIO, Inc. launched the new OSSIOfiber Compression Staple. OSSIOfiber Compression Staples are made with OSSIOfiber Intelligent Bone Regeneration Technology. OSSIOfiber provides the first credible solution to the shortcomings of permanent metal hardware and conventional resorbable and allograft implants by combining unparalleled mechanical strength and natural bone healing in a non-permanent implant.

Additionally, in December 2022, Abbott Laboratories launched its latest-generation transcatheter aortic valve implantation (TAVI) system called Navitor by making the minimally invasive device available for people with severe aortic stenosis who are at high or extreme surgical risk. Hence, due to the above factors, the market is expected to boost over the forecast period.

Favorable Reimbursement Policies are Boosting the Medical Implants Market

Reimbursement policies often consider factors such as the complexity of the procedure, the type of implant used, and the associated healthcare resources utilized during the procedure. Reimbursement policies play a crucial role in the medical implant market as they determine the level of coverage and financial reimbursement provided to healthcare providers for performing implantation procedures.

For instance, in March 2023, Inspire Medical Systems, Inc. stated that it has received countrywide reimbursement approval in Belgium, effective at rates consistent with other countries around the world. This reimbursement approval provides a pathway to open additional Inspire implanting centers in Belgium, under the guidance of Antwerp University Hospital (UZA) while also expanding access to care.

Additionally, in November 2022, Establishment Labs Holdings Inc. declared that Motiva Implants and the Motiva Flora tissue expander have been approved for use in Japan by the Pharmaceuticals and Medical Devices Agency (PMDA), and these products have also received reimbursement for post-mastectomy reconstruction under the Japanese National Health System.

Complications Associated with Dental Implants Will Hamper the Growth of the Market

Complications of dental implants include osseointegration where the bone grows around your implant and it can fall out on its own. One major dental implant risk is sinus damage where the upper jaw is directly under the nasal sinuses. Implants that are used to replace the top teeth can potentially penetrate into the sinus which leads to discomfort or possible infection. There are similar instances with other implants and thus these are expected to hamper the market growth.

Segment Analysis

The global medical implants market is segmented based on product, material type, end users, and region.

Orthopedic Implants is expected to hold the largest market share over the period forecast owing to increasing product launches. An orthopedic implant is a manufactured device designed to replace a joint, bone, or cartilage due to damage or deformity such as from breaking a leg, losing a limb, or a congenital defect.

For instance, in February 2023, CurvaFix, Inc. launched its smaller-diameter, 7.5mm CurvaFix IM Implant which is designed to simplify surgery and provide strong, stable fixation in small-boned patients. The company showcases the new 7.5mm intramedullary device, of which over two dozen have already been implanted in patients, at the American Academy of Orthopedic Surgeons (AAOS) 2023 Annual Meeting.

Additionally, in July 2023, The Orthopaedic Implant Company commercially launched of its innovative Threaded Metacarpal Nail System. The Threaded Metacarpal Nail System features a low insertion torque and minimally compressive design, ensuring optimal stability for various fracture patterns.

Geographical Penetration

North America Accounted for Approximately 38.4% of the Market Share in 2022

The global medical implants market is segmented into North America, Europe, Asia Pacific, South America, Middle East, and Africa. North America has maintained a significant proportion of the medical implants market in recent years, and this trend is anticipated to continue throughout the forecast period due to factors such as the rising incidence of knee and hip replacements, and product launches in medical implants.

For instance, The American Joint Replacement Registry (AJRR), published its 2022 Annual Report on hip and knee arthroplasty procedural trends and patient outcomes. The annual report demonstrates an overall cumulative procedural volume growth of 14% compared to the previous year and includes over 2.8 million hip and knee procedures since 2012 from over 1,250 hospitals, ambulatory surgery centers (ASCs), and private practice groups. The number of procedures submitted by ASCs has grown exponentially between 2012 and 2020 and has increased by 57%.

Additionally, according to the Aesthetic Society, there were 365,000 breast implantations performed in 2021. In addition, 148,000 women had implants removed and replaced, and 71,000 had their implants removed and not replaced in the United States. Hence, the above factors help accelerate the region's growth.

Competitive Landscape

The major global players in the market include: Orthopedic Implant Company, Auxein Medical, Medtronic Plc., Stryker Corporation, 4Web Medical, Smith & Nephew, Novel Biocare Services AG, Strauman AG, GS Medical, CurvaFix Inc. among others.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the medical implants market. The onset of the pandemic in early 2020 led to widespread lockdowns and restrictions, impacting regular check-ups, appointments, device implantations, and consultations worldwide. Many hospitals are focused on COVID-19 cases, and this reduced cardiac surgery in many patients suffering from chronic disease.

Moreover, the focus of research and development efforts shifted during the pandemic, with a significant emphasis on developing vaccines and treatments for COVID-19. Therefore, owing to the above factors, the medical implants market is expected to be moderately affected over the forecast period.

By Product

  • Orthopedic Implant
    • Hip Implants
    • Joint Replacement Implant
    • Spine Implant
    • Others
  • Cardiovascular Implants
    • Pacemakers
    • Implantable Cardioverter Defibrillator (ICD)
    • Cardiac Loop Recorders
  • Ophthalmic Implants
    • Trifocal lens
    • Extended-depth-of-focus (EDOF) lens implant
    • Monofocal lens implant
  • Dental Implants
    • Endosteal
    • Subperiosteal
  • Cosmetic Implants
    • Facial Implants
    • Breast Implants

By Material Type

  • Ceramic
  • Metallic
    • Titanium
    • Cobalt
    • Tantalum
    • Nickel
    • Others
  • Polymers
  • Others

By End Users

  • Hospitals
  • Orthopedic Centers
  • ASCs
  • Cardiac Centers
  • Facial Aesthetics Centers
  • Dental Hospitals
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In December 2022, Abbott Laboratories received the U.S. Food and Drug Administration (FDA) approval of the company's Eterna spinal cord stimulation (SCS) system which is the smallest implantable, rechargeable spinal cord stimulator.
  • In Aug 2023, 4WEB Medical, an orthopedic implant company focused on developing innovative implants that utilize its proprietary Truss Implant Technology launched the newest addition to the company's implant portfolio, the Cervical Spine Plating Solution (CSTS-PS).
  • In June 2023, Medics invested £1.8 million for clinical trials with the aim of precisely targeting heart patients who need tiny defibrillators to be fitted under their skin with the aim of reducing deaths from sudden cardiac arrests.

Why Purchase the Report?

  • To visualize the global medical implants market segmentation based on product, material type, end users, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global medical implants market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global medical implants market report would provide approximately 69 tables, 70 figures, and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Material Type
  • 3.3. Snippet by End Users
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Product Launches for Medical Implants
      • 4.1.1.2. Favorable Reimbursement Policies
    • 4.1.2. Restraints
      • 4.1.2.1. Complications Associated with Dental Implants
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Unmet Needs
  • 5.4. Regulatory Analysis
  • 5.5. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Orthopedic Implant
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 7.2.3. Hip Implants
    • 7.2.4. Joint Replacement Implant
    • 7.2.5. Spine Implant
    • 7.2.6. Others
  • 7.3. Cardiovascular Implants
    • 7.3.1. Pacemakers
    • 7.3.2. Implantable Cardioverter Defibrillator (ICD)
    • 7.3.3. Cardiac Loop Recorders
  • 7.4. Ophthalmic Implants
    • 7.4.1. Trifocal lens
    • 7.4.2. Extended-depth-of-focus (EDOF) lens implant
    • 7.4.3. Monofocal lens implant
  • 7.5. Dental Implants
    • 7.5.1. Endosteal
    • 7.5.2. Subperiosteal
  • 7.6. Cosmetic Implants
    • 7.6.1. Facial Implants
    • 7.6.2. Breast Implants

8. By Material Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 8.1.2. Market Attractiveness Index, By Material Type
  • 8.2. Ceramic
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Metallic
  • 8.4. Polymers
  • 8.5. Others

9. By End Users

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
    • 9.1.2. Market Attractiveness Index, By End Users
  • 9.2. Hospitals
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Orthopedic Centers
  • 9.4. ASCs
  • 9.5. Cardiac Centers
  • 9.6. Facial Aesthetics Centers
  • 9.7. Dental Hospitals
  • 9.8. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Product Benchmarking
  • 11.3. Company Share Analysis
  • 11.4. Key Developments and Strategies

12. Company Profiles

  • 12.1. Orthopedic Implant Company*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Auxein Medical
  • 12.3. Medtronic Plc.
  • 12.4. Stryker Corporation
  • 12.5. 4Web Medical
  • 12.6. Smith & Nephew
  • 12.7. Novel Biocare Services AG
  • 12.8. Strauman AG
  • 12.9. GS Medical
  • 12.10. CurvaFix Inc.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us